Lilly points to low-dose Zepbound and Foundayo as weight loss maintenance options

May 12, 2026 06:01 PM EDT PharmaGLP-1 drugs Lil­ly points to low-dose Zep­bound and Foun­dayo as weight loss main­te­nance op­tions Elizabeth Cairns Senior biopharma journalist Re­duc­ing the dose of Eli Lil­ly’s obe­si­ty shot Zep­bound could pro­vide a safe, ef­fec­tive and po­ten­tial­ly cheap­er op­tion for the main­te­nance of weight loss, ac­cord­ing … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER